Erratum: Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1. (Blood (2017) 129, 21 (2896-2907) DOI: 10.1182/blood-2016-09-742825);Phagocytes, granulocytes, & myelopoiesis: Plasmin & plasminogen induce macrophage reprogramming & regulate key steps of inflammation resolution via annexin A1

Blood

Volumn 129, Issue 21, 2017, Pages 2896-2907

  Sugimoto, Michelle A ^a,b,c   Ribeiro, Ana Luíza C ^a,c,d   Costa, Bruno R C ^a,c,d   Vago, Juliana P ^a,c   Lima, Kátia M ^a,c   Carneiro, Fernanda S ^a,c   Ortiz, Mylena Maira O ^a,c   Lima, Graziele Letícia N ^a,c   Carmo, Aline A F ^a,c   Rocha, Renata M ^c   Perez, Denise A ^c   Reis, Alessandra C ^c   Pinho, Vanessa ^c   Miles, Lindsey A ^e   Garcia, Cristiana C ^f   Teixeira, Mauro M ^c   Sousa, Lirlandia P ^a,b,c,d  

^a Department of Clinical and Toxicological Analyses   (Brazil)

^b School of Pharmacy   (United States)

^c Department of Biochemistry and Immunology   (United States)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARGINASE 1; CD206 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOCORTIN 1; PLASMIN; PLASMINOGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANNEXIN A1, MOUSE; DIFFERENTIATION ANTIGEN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL SURVIVAL; CONTROLLED STUDY; EFFEROCYTOSIS; EXPERIMENTAL INFLAMMATION; EXPERIMENTAL PLEURISY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; NUCLEAR REPROGRAMMING; PERITONEUM MACROPHAGE; PHENOTYPE; PLEURA CAVITY; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL; PATHOLOGY; RAW 264.7 CELL LINE;

ACUTE DISEASE; ANIMALS; ANNEXIN A1; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELLULAR REPROGRAMMING; FIBRINOLYSIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; PLASMINOGEN; RAW 264.7 CELLS;

EID: 85019661338     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2018-05-854158     Document Type: Erratum

References (70)

1. Sousa LP, Alessandri AL, Pinho V, Teixeira MM. Pharmacological strategies to resolve acute inflammation. Curr Opin Pharmacol. 2013;13(4): 625-631.
2. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871-882.
3. Alessandri AL, Sousa LP, Lucas CD, Rossi AG, Pinho V, Teixeira MM. Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol Ther. 2013;139(2): 189-212.
4. Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of inflammation: What controls its onset? Front Immunol. 2016;7:160.
5. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014; 14(3):166-180.
6. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1):62-70.
7. Sugimoto MA, Vago JP, Teixeira MM, Sousa LP. Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance. J Immunol Res. 2016;2016: 8239258.
8. Labonte AC, Tosello-Trampont AC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases. Mol Cells. 2014;37(4): 275-285.
9. Ariel A, Serhan CN. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol. 2012;3:4.
10. Lichtnekert J, Kawakami T, Parks WC, Duffield JS. Changes in macrophage phenotype as the immune response evolves. Curr Opin Pharmacol. 2013;13(4):555-564.
11. Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol. 2012;92(3):509-519.
12. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 1998;91(6): 2005-2009.
13. Wygrecka M, Marsh LM, Morty RE, et al. Enolase- 1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood. 2009;113(22):5588-5598.
14. Gong Y, Hoover-Plow J. The plasminogen system in regulating stem cell mobilization. J Biomed Biotechnol. 2012;2012:437920.
15. Carmo AA, Costa BR, Vago JP, et al. Plasmin induces in vivo monocyte recruitment through protease-Activated receptor-1-, MEK/ERK-, and CCR2-mediated signaling. J Immunol. 2014; 193(7):3654-3663.
16. Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008;118(9):3012-3024.
17. Pluskota E, Soloviev DA, Szpak D, Weber C, Plow EF. Neutrophil apoptosis: Selective regulation by different ligands of integrin alphaMbeta2. J Immunol. 2008;181(5): 3609-3619.
18. Rosenwald M, Koppe U, Keppeler H, et al. Serum-derived plasminogen is activated by apoptotic cells and promotes their phagocytic clearance. J Immunol. 2012;189(12):5722-5728.
19. Das R, Ganapathy S, Settle M, Plow EF. Plasminogen promotes macrophage phagocytosis in mice. Blood. 2014;124(5): 679-688.
20. Borg RJ, Samson AL, Au AE, et al. Dendritic cellmediated phagocytosis but not immune activation is enhanced by plasmin. PLoS One. 2015;10(7): E0131216.
21. Hannon R, Croxtall JD, Getting SJ, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 2003;17(2): 253-255.
22. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol. 2011;41(2): 366-379.
23. Vago JP, Nogueira CR, Tavares LP, et al. Annexin A1 modulates natural and glucocorticoidinduced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol. 2012;92(2): 249-258.
24. Sousa LP, Lopes F, Silva DM, et al. PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaBindependent manner. J Leukoc Biol. 2010; 87(5):895-904.
25. Vago JP, Tavares LP, Sugimoto MA, et al. Proresolving actions of synthetic and natural protease inhibitors are mediated by annexin A1. J Immunol. 2016;196(4):1922-1932.
26. Vago JP, Tavares LP, Garcia CC, et al. The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution. J Immunol. 2015;194(10):4940-4950.
27. Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TEN, Perretti M. The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol. 2011; 179(1):259-269.
28. Newson J, Stables M, Karra E, et al. Resolution of acute inflammation bridges the gap between innate and adaptive immunity. Blood. 2014; 124(11):1748-1764.
29. Casella G, Garzetti L, Gatta AT, et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J Neuroinflammation. 2016;13(1):139.
30. Fernando MR, Reyes JL, Iannuzzi J, Leung G, McKay DM. The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. PLoS One. 2014;9(4):e94188.
31. Mauer J, Chaurasia B, Goldau J, et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesityassociated resistance to insulin. Nat Immunol. 2014;15(5):423-430.
32. Laumonnier Y, Syrovets T, Burysek L, Simmet T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood. 2006; 107(8):3342-3349.
33. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. Modulation of macrophage efferocytosis in inflammation. Front Immunol. 2011;2:57.
34. Hochreiter-Hufford A, Ravichandran KS. Clearing the dead: Apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol. 2013;5(1):a008748.
35. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calciumdependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 2003;17(11): 1544-1546.
36. Dalli J, Consalvo AP, Ray V, et al. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J Immunol. 2013;190(12):6478-6487.
37. Scannell M, Flanagan MB, deStefani A, et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol. 2007;178(7):4595-4605.
38. Dalli J, Jones CP, Cavalcanti DM, Farsky SH, Perretti M, Rankin SM. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB J. 2012;26(1): 387-396.
39. Meznarich J, Malchodi L, Helterline D, et al. Urokinase plasminogen activator induces profibrotic/m2 phenotype in murine cardiac macrophages. PLoS One. 2013;8(3):e57837.
40. Carlson S, Helterline D, Asbe L, et al. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator [published online ahead of print 1 June 2016]. J Mol Cell Cardiol. doi:10.1016/j.yjmcc.2016.05.016.
41. Capote J, Kramerova I, Martinez L, et al. Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a proregenerative phenotype. J Cell Biol. 2016;213(2): 275-288.
42. Genua M, D'Alessio S, Cibella J, et al. The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation [published correction appears in Gut. 2015;64(9):1465]. Gut. 2015;64(4):589-600.
43. Won S, Lee JK, Stein DG. Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats. Brain Behav Immun. 2015; 49:267-279.
44. Lin L, Jin Y, Hu K. Tissue-Type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-Activated protein kinase (MAPK) pathway. J Biol Chem. 2015;290(12):7910-7917.
45. Fuster JJ, Walsh K. The good, the bad, and the ugly of interleukin-6 signaling. EMBO J. 2014; 33(13):1425-1427.
46. McFarland-Mancini MM, Funk HM, Paluch AM, et al. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol. 2010;184(12):7219-7228.
47. Xing Z, Gauldie J, Cox G, et al. IL-6 is an anti inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101(2):311-320.
48. Kostek MC, Nagaraju K, Pistilli E, et al. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse. BMC Musculoskelet Disord. 2012;13:106.
49. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio JA, Nicholson AC. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem. 1993;268(16):11951-11958.
50. Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-Associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol. 1996;15(2):252-259.
51. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol. 1990;110(4):1361-1367.
52. Motley MP, Madsen DH, Jürgensen HJ, et al. A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. Blood. 2016;127(9):1085-1096.
53. Shen Y, Guo Y, Mikus P, et al. Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood. 2012;119(24):5879-5887.
54. Sulniute R, Shen Y, Guo YZ, et al. Plasminogen is a critical regulator of cutaneous wound healing. Thromb Haemost. 2016;115(5):1001-1009.
55. Min HY, Semnani R, Mizukami IF, Watt K, Todd RF III, Liu DY. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol. 1992;148(11):3636-3642.
56. Kamio N, Hashizume H, Nakao S, Matsushima K, Sugiya H. IL-1beta stimulates urokinase-Type plasminogen activator expression and secretion in human dental pulp cells. Biomed Res. 2007;28(6): 315-322.
57. Narita T, Muromachi K, Kamio N, Nakao S, Matsushima K, Hashizume H. Tumor necrosis factor a stimulates expression and secretion of urokinase plasminogen activator in human dental pulp cells. J Oral Sci. 2012;54(4):329-336.
58. Mitchell JW, Baik N, Castellino FJ, Miles LA. Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood. 2006;107(11): 4383-4390.
59. Chen Z-L, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. 1997;91(7):917-925.
60. Rossignol P, Ho-Tin-Noé B, Vranckx R, et al. Protease nexin-1 inhibits plasminogen activationinduced apoptosis of adherent cells. J Biol Chem. 2004;279(11):10346-10356.
61. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med. 1996;2(11):1259-1262.
62. McArthur S, Gobbetti T, Kusters DH, Reutelingsperger CP, Flower RJ, Perretti M. Definition of a novel pathway centered on lysophosphatidic acid to recruit monocytes during the resolution phase of tissue inflammation. J Immunol. 2015;195(3):1139-1151.
63. Arur S, Uche UE, Rezaul K, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003;4(4):587-598.
64. Maderna P, Yona S, Perretti M, Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasonetreated macrophages and annexin-derived peptide Ac(2-26). J Immunol. 2005;174(6): 3727-3733.
65. Leoni G, Neumann PA, Kamaly N, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 2015;125(3):1215-1227.
66. Babbin BA, Laukoetter MG, Nava P, et al. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol. 2008;181(7): 5035-5044.
67. McArthur S, Cristante E, Paterno M, et al. Annexin A1: A central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol. 2010;185(10):6317-6328.
68. Brownstein C, Deora AB, Jacovina AT, et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: Enhanced expression by macrophages. Blood. 2004;103(1): 317-324.
69. Felez J, Miles LA, Plescia J, Plow EF. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines. J Cell Biol. 1990;111(4):1673-1683.
70. Andronicos NM, Chen EI, Baik N, et al. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 2010;115(7):1319-1330.